Fundings, 2010

2017   2016   2015   2014   2013   2012   2011   2010   2009

2010

December

  • REVA Medical has raised $84 million in a public offering (drug-eluting bioresorbable coronary stent)
  • EnteroMedics, Inc., has raised $27.6 million in a public stock offering (vagal nerve block system for treatment of obesity)
  • Unilife Corp. has raised A$23.1 million (US $22.8 million) in funding (syringes)
  • TYRX, Inc., has raised $20 million in a private placement (products to reduce infection associated with implantable pacemakers and defibrillators)
  • Semprus Biosciences Corp. has raised $13 million in funding (technology to make medical devices resistant to bacterial infection)
  • Endologix, Inc., has raised $15 million of a planned $54 million round of funding according to a regulatory filing (self-expandable stent graft for the endovascular repair of abdominal aortic aneurysms)
  • In Vivo Therapeutics has closed on $13 million in funding (polymers in use for treatment of traumatic spinal cord injury)
  • Histogen, Inc., has raised $10 million in a Series A funding round (fibroblasts for tissue regeneration)
  • Lutonix, Inc., has raised $10 million of a planned $45 million Series C funding round according to a regulatory filing (drug coated balloon catheters)
  • Bonovo Orthopedics, Inc., has raised $10 million in Series C funding (orthopedic implants for the Chinese market)
  • Sunshine Heart, Inc., has raised $9.4 million in a new round of funding (counterpulsation for treatment of heart failure)
  • BridgePoint Medical, Inc., has raised $9 million in funding according to a regulatory filing (balloon catheter system to treat chronic coronary and peripheral total occlusions)
  • Estech has raised $8.5 million in funding (minimally invasive cardiac ablation)
  • Vertiflex., Inc., has raised $8.4 million of a planned $12 million funding round according to a regulatory filing (motion preserving spine surgery technologies)
  • NeuWave Medical, Inc., has raised $5.55 million of a planned $8 million funding round (energy-based minimally invasive medical devices)
  • Innocoll Holdings, Inc., has raised $5.25 million in funding according to regulatory filing (biodegradable surgical implants)
  • Cardiovascular Systems, Inc., has raised $1.5 million in funding according to a regulatory filing (products for treatment of peripheral artery disease)
  • Oraya Therapeutics, Inc., has raised $5 million in funding according to a regulatory filing (noninvasive robotically controlled treatments for inflammatory and neovascular diseases of the eye)
  • GT Urological, Inc., has raised $4.56 million in a round of funding according to a regulatory filing (urinary incontinence device)
  • ExtraOrtho, Inc., has raised $3.62 million in funding according to a regulatory filing (external fixation systems)
  • Second Sight Medical Products, Inc., has raised $3.5 million in funding according to a regulatory filing (retinal prosthesis)
  • Exogenesis Corp. has raised $3.19 million in funding (gas cluster ion beam technology for treating medical device implant surfaces)
  • Neograft Technologies, Inc., has raised $3 million in funding according to a regulatory filing (polymer graft technology for use in treatment of coronary artery disease)
  • Cambridge Heart, Inc., has raised $2.9 million in a round of funding according to a regulatory filing (cardiac diagnostics)
  • Pivot Medical, Inc., has raised $2.725 million of a planned $5 million round of funding according to a regulatory filing (non-spine orthopedic technologies)
  • Palmaz Scientific, Inc., has raised $2.5 million of a planned $7.5 million funding round according to a regulatory filing (coronary stent technology)
  • BioPoly, LLC (subsidiary of Schwartz Biomedical), has raised $2.5 million in funding according to a regulatory filing (orthopedic implants)
  • Onset Medical Corp. has raised $2.137 million of a planned $2.202 million round of funding (percutaneous access technology for endourology clinical applications)
  • Ortho Kinematics has raised $2 million in startup funding (diagnostics based on spinal motion analysis)
  • Capricor, Inc., has raised $2 million in funding (stem cell therapies for cardiac disease)
  • Anterios, Inc., has raised $2 million in funding according to a regulatory filing (nanotechnology-based drug delivery)
  • BrainScope Company, Inc., has raised $1.6 million of a planned $3 million funding round according to a regulatory filing (non-invasive instruments for diagnosis of traumatic brain injury)
  • Bespoke Innovations, Inc., has raised $1.575 million in funding according to a regulatory filing (prosthetic limbs)
  • Minimally Invasive Devices, Inc., has raised $1.5 million according to a regulatory filing (devices to assist in laparoscopy)
  • Spinnaker Biosciences, Inc., has raised $1 million of a planned $3 million round of funding according to a regulatory filing (ophthalmic drug delivery)
  • Asalus Medical Instruments has raised $791,000 (£510,000) in new funding (products to facilitate laparoscopic surgery)
  • Spinal Simplicity, LLC, has raised $703K of a planned $4 million round of financing according to a regulatory filing (interspinous fusion cages)
  • Cardica Inc. has raised $600K of a planned $10 million funding round (surgical stapling devices)
  • Tayside Flow Technologies has raised $466,000 (£300,000) in new funding (devices based on spiral laminal flow dynamics)
  • Salutaris Medical Devices, Inc., has raised $350K of a planned $1.5 million funding round (nerve stimulation and other technologies for treatment of a variety of conditions)
  • JMEA Corp. has raised $189K of a planned $5.25 million round of funding according to a regulatory filing (orthopedic implants)

November

  • Vascular Pathways, Inc., has raised $14 million in a Series B funding (medical devices for peripheral intravenous access)
  • Intersect ENT, Inc., has raised $30 million in a Series C funding (bioabsorbable stent for treatment of chronic sinusitis)
  • Flex Biomedical, Inc., has raised $694K in a round of funding (osteoarthritis and other treatments in orthopedics)
  • InterRad Medical, Inc., has raised $1.9 million of a planned $6 million round (products for use in interventional procedures)
  • Claret Medical, Inc., has raised $163K out of a planned $1 million round of funding (embolic protection devices)
  • Seno Medical Instruments, Inc., has raised $4.57 million of a planned $5.27 million funding round (laser opto-acoustic imaging for early cancer detection)
  • NxThera Inc. has raised $2 million in funding (device treatments for benign prostatic hypertrophy)
  • nContact Surgical, Inc., has raised $16 million in funding, following a round of $13.1 million in October (treatment of atrial fibrillation)
  • Sernova Corp. has raised $1 million in new funding (islet cell transplant technology for diabetes)
  • Generic Medical Devices, Inc., has raised $4.35 million of a planned $7.85 million round (sling for stress UI and patches for ventral and inguinal hernia)
  • BridgePoint Medical, Inc., has raised $1 million in a new round of funding according to a regulatory filing (devices for coronary and peripheral vascular interventions)
  • Orasi Medical, Inc., has raised $1.77 million of a planned $2.63 million round of funding according to a regulatory filing (non-invasive neurology diagnosis and monitoring)
  • BeneChill, Inc., has raised $600K of a planned $1.2 million round of funding according to a regulatory filing (devices for treatment of stroke)
  • BSD Medical, Inc., is receiving $10.4 million in funding Downsview Capital and Kingsbrook Partners (RF and microwave ablation of cancer and other diseases)
  • Nanospectra Biosciences, Inc., has raised $873K of a planned $1.2 million round of financing according to a regulatory filing (particle-based ablation of tumors)
  • Minerva Biotechnologies Corp. has raised $4.63 million of a planned $5.9 million round of financing according to a regulatory filing (nanoparticle applications in biochips, cancer)
  • ImThera Medical, Inc., has raised $1.03 million of a planned $2.2 million funding round according to a regulatory filing (neurostimulation devices for treatment of obstructive sleep apnea)
  • Novan, Inc., has raised $3 million of a planned $4 million round of financing according to a regulatory filing (nitric-oxide releasing nanoparticle technology for wound care and infection control)
  • Sonoma Orthopedic Products has raised $1.5 million in a round of venture funding (implants for fracture fixation)
  • Bacterin International Holdings, Inc., has raised $9 million of a planned $14 million funding round (bone graft material and anti-infective coatings)
  • Minerva Surgical, Inc., has raised $2 million of a planned $3 million funding round (endometrial ablation)
  • HyperBranch Medical Technology, Inc., has raised $2.072 million in a funding round according to a regulatory filing (products for ocular surgery including ophthalmic surgical adhesive)
  • IsoRay, Inc., has raised $2.25 of a planned $4.43 million round (brachytherapy in cancer)
  • BioQuiddity, Inc., has raised $7 million in funding according to a regulatory filing (drug infusion devices)
  • Access Scientific, Inc., has raised $2 million in funding (device to facilitate insertion of peripherally inserted central catheters)
  • Sunshine Heart, Inc., has raised $3.5 million in funding according to a regulatory filing (device for treatment of heart failure)

October

  • IDEV Technologies has raised $46 million in a Series D funding (endovascular and interventional device technologies)
  • NinePoint Medical, Inc., has raised $33 million in a Series A funding (in vivo pathology device to enable treatment of cancer during biopsy)
  • GC Aesthetics Ltd has raised $30 million in funding (implants for aesthetics)
  • Symetis SA has raised $25.8 million in a funding round (transcatheter aortic valve implantation)
  • World Heart Corp. is raising $25.3 million in equity financing (circulatory support systems)
  • InfraReDx, Inc., has raised $21 million in financing (cardiovascular diagnostic imaging)
  • TriReme Medical, Inc., has raised $17 million in a Series D funding (stents for treatment of bifurcated lesions)
  • Endologix, Inc., has received a $15 million investment toward its acquisition of Nellix Endovascular (both companies make stents for treatment of AAA)
  • Cappella, Inc., has raised $14.6 million (€10.5 million) in a Series D funding (stents for bifurcated vascular disease)
  • ALung Technologies, Inc., has raised $14 million in new funding (artificial lung device)
  • nContact Surgical, Inc., has raised $13.15 million of a planned $23.15 million funding round (ablation and tissue coagulation technologies)
  • Cytomedix, Inc., has raised $13 million in funding (regenerative therapies for wound care, inflammation and angiogenesis)
  • EarlySense, Inc., has raised $7 million in funding (patient monitoring system)
  • Glumetrics, Inc., has raised $5 million of a planned $5.5 million round of funding according to a regulatory filing (intravascular continuous blood glucose monitor)
  • Altea Therapeutics Corp. has raised $5 million of a planned $10 million funding round according to a regulatory filing (transdermal drug delivery)
  • Minnow Medical, Inc., has raised $4.7 million in funding (radiofrequency thermoplasty for treatment of in-stent restenosis)
  • SurgiVision, Inc., has raised $3 million in funding according to a regulatory filing (MRI-guided surgical intervention)
  • Telecardia, Inc., has raised $2.5 million in funding according to a regulatory filing (implantable device for early detection of myocardial infarction)
  • HemoSonics, LLC, has raised $2 million in a recent funding (technologies to identify abnormal clotting)
  • Neurolink, Inc., has raised $1.617 million of a planned $3.234 million round of funding (implantable device to predict seizures and treat via intracranial drug delivery)
  • Corhythm Inc. has raised $1.556 million in funding according to a regulatory filing (implantable device for detection of detects early onset of atrial fibrillation and chronic heart failure)
  • Acuity Medical, Inc., has raised $1.5 million in a new round of equity funding (device-based treatment of macular degeneration)
  • RSB Spine LLC has raised $1.5 million in a round of funding (spinal implants)
  • Theracell, Inc., has raised $1.344 million of a planned $6 million round of funding according to regulatory filing (personalized stem cell therapy)
  • VesOcclude Medical, LLC, has raised $1.28 million in funding according to a regulatory filing (vessel ligating clips)
  • Clear Catheter Systems, Inc., has raised $1.2 million in funding (technology to keep catheters clear of blood, other fluid)
  • Advanced Cardiac Therapeutics has raised $1.197 million of a planned $3.2 million round of funding according to a regulatory filing (cardiac ablation catheters)
  • Miramar Labs has raised $1 million in funding according to a regulatory filing (electromagnetic deactivation of sweat glands)
  • CardiOx Corp. has raised $650K in funding (non-invasive device to detect patent foramen ovale)
  • SonoMedica, Inc., has raised $500K of a planned $1.5 million round of funding according to a regulatory filing (sound-based detection of heart and vascular irregularities)
  • Solx, Inc., has raised $3.7 million of a planned $7.2 million funding round (laser treatment of glaucoma)
  • Virtual Incision Corporation has raised $2 million in a Series A funding (in vivo robotics for single incision laparoscopy)

September

  • Accumetrics, Inc., has raised $24 million in funding from existing investors (devices to measure antiplatelet therapy)
  • SyneCor, LLC, has raised $10 million in funding according to a regulatory filing (device technologies in interventional cardiology)
  • Second Sight Medical Products, Inc., has raised $1.5 million of a planned $3 million round of funding according to a regulatory filing (retinal prosthesis)
  • superDimension Ltd. has raised $24.8 million ($9.8 million equity and $15 million credit) in financing (minimally invasive interventional pulmonology devices)
  • Amedica Corp. has raised $30 million ($15 million each in debt, equity) in financing (spine and total joint implants)
  • CardioRobotics, Inc., has raised $500K of a planned $5 million round of financing (surgical robotics)
  • ECW Therapeutics, Inc., has raised $200K of a planned $500K in funding (autologous stem cell systems)
  • MAX Endoscopy, Inc., has received $250K in funding from JumpStart, Inc. (fiberoptic device for treatment of hemorrhoids)
  • BioTectix, LLC, has received $3 million in investment from founding investment firm Allied Minds (polymer materials and coatings for implantable medical devices)
  • Orthopedic Designs North America, Inc., has received $3 million in funding according to a regulatory filing (orthopedic fixation devices)
  • Humacyte, Inc., has raised $12 million in funding according to a regulatory filing (tissue engineering)
  • CardioMEMS has received a $60 million investment from St. Jude Medical (MEMS technology for cardiovascular disease, including congestive heart failure, and others)
  • SonarMed, Inc., has raised $1.03 million in funding according to a regulatory filing (technologies to aid intubation)
  • Guided Therapeutics, Inc., has raised $3.055 million of a planned $5 million round of funding according to a regulatory filing (technologies to detect precancerous cervical disease)
  • CloSys Corp. has raised $1.49 million of a planned $2.38 million round of investment (vascular closure devices)
  • Tryton Medical has received $20 million in a Series D round of funding (stents for bifurcated lesions)
  • Lantos Technologies, Inc., has raised $1.6 million in funding according to regulatory filing (3D imaging of ear canal)
  • DGIMED ORHTO, Inc., has raised $1.56 million of a planned $3.5 million funding round according to a regulatory filing (orthopedic implants)
  • CardiaLen, Inc., has raised $305K in funding according to a regulatory filing (cardioverters for atrial fibrillation)
  • Arterial Remodeling Technologies has raised $8.5 million in a new funding round (fully resorbable coronary stents)
  • Sadra Medical, Inc., has raised $4 million in funding according to a regulatory filing (endovascular aortic valve replacement)
  • Orthocare Innovations has raised $3 million in funding according to a regulatory filing (orthotics and prosthetics based on sensor and actuation technologies)
  • Aura Biosciences, Inc., has raised $1.425 million according to a regulatory filing (nanotechnology based drug delivery)
  • Glaukos Corp. has raised $6 million in funding according to a regulatory filing (technologies for treatment of glaucoma)
  • Rhythmia Medical, Inc., has raised $5 million of a planned $7 million funding round according to a regulatory filing (device treatment for cardiac arrhythmia)
  • ProUroCare Medical, Inc., has raised $3 million in financing (prostate imaging system)
  • Transave Inc. has raised $2 million of a planned $6 million round according to a regulatory filing (liposomal drug delivery)
  • Cabochon Aesthetics, Inc., has raised $1.4 million of a planned $2 million round of funding (medical devices for the aesthetic treatment of cellulite)
  • Ophthonix, Inc., has raised $5.4 million of a planned $12.1 million funding round (vision correction)
  • Anaxsys Ltd. has raised $1.58 million (£1 million) in funding (respiratory sensor devices for asthma, sleep apnea and lung cancer)
  • EnteroMedics, Inc., has raised $6.3 million in a Series A funding round (neuroblocking devices for treatment of obesity and other GI diseases)
  • Caymus Medical, Inc., has raised $1 million in funding (undisclosed medical technology from previous founder of Opus Medical)
  • Combinent BioMedical Systems, Inc., has raised $500K in funding according to a regulatory filing (transvaginal drug delivery system)
  • Ellipse Technologies, Inc., has raised $1.58 million of a planned $2 million round of funding (system for treatment of spinal scoliosis)

August

  • Fibrocell Science, Inc., has raised $2.7 million in a round of funding according to a regulatory filing (autologous cell therapies)
  • SpectraScience, Inc., has raised $3.15 million of a planned $5 million round of funding according to a regulatory filing (“optical biopsy” cancer detection)
  • NXThera, Inc., has raised $1 million in funding according to a regulatory filing (minimally invasive treatment of benign prostatic hypertrophy and other men’s health)
  • SPO Medical, Inc., has raised $438K of a planned $1.02 million round of funding (reflectance pulse oximetry)
  • ImThera Medical, Inc., has raised $3.5 million in a round of funding according to a regulatory filing (neurostimulation for treatment of sleep apnea)
  • Cardioxyl Pharmaceuticals, Inc., has raised $15 million in funding (heart failure drug)
  • Paringenix, Inc., has raised $4.39 million of a planned $5 million round of funding according to a regulatory filing (developing a modified form of heparin to ameliorate cardiac ischemia-reperfusion injury following myocardial infarction)
  • Clear Vascular, Inc., has raised $5.42 million in funding according to a regulatory filing (Implant for the treatment of luminal hyperplasia)
  • InspireMD Ltd. has raised $1.58 million in funding according to a regulatory filing (stents for myocardial infarction, carotid intervention and other vascular and non-vascular applications)
  • Neodyne Biosciences, Inc., has raised $5.76 million in funding according to a regulatory filing (investigational device for post-surgical incision care)
  • Nephera, Inc., has raised $2.85 million in its second round of funding (device for treatment of congestive heart failure)
  • Orthos, Ltd, has raised $1.3 million in a round of funding (bone substitutes)
  • SI-BONE, Inc., has raised $11 million in a round of funding (minimally invasive device for treatment of the sacroiliac joint)
  • nContact Surgical, Inc., has raised $4 million in a round of funding according to a regulatory filing (endoscopic treatment of arrhythmia)
  • Cardiac Concepts, Inc., has raised $27.2 million in funding according to a regulatory filing (products for treatment of heart failure and sleep apnea)
  • Domain Surgical, Inc., has raised $1.255 million in funding according to a regulatory filing (development stage medical device company)
  • Response Biomedical Corp. has received $7.725 million in funding according to a regulatory filing (point-of-care diagnostics)
  • Arsenal Medical, Inc., has raised $3 million in funding according to a regulatory filing (biomaterials-based therapeutics based on bioactive composites)
  • BenVenue Medical, Inc., has raised $4.45 million of a planned $31 million round of financing (minimally invasive spine surgery)
  • Mardil, Inc., has raised $1.55 million of a planned $6.5 million funding round according to a regulatory filing (minimally invasive treatment of congestive heart failure)
  • NeuroVista, Inc., has raised $21.5 million in an equity and convertible debt funding (implantable device for treatment of epilepsy)
  • ViewRay, Inc., has raised $20 million in a Series C financing (MRI-guided radiotherapy)
  • Cardiac Concepts, Inc. has raised $27.2 million in funding (neurostimulation device for treatment of congestive heart failure and sleep apnea)
  • Golden Meditech has raised $40 million in equity funding (autologous blood recovery system)
  • EndoGastric Solutions, Inc., has raised $30 million in Series F funding (natural orifice surgery)
  • Aptus Endosystems, Inc., has raised $15 million in a “Series AA” round of funding (endovascular aneurysm repair)
  • ClearCount Medical, Inc., has raised $5 million in a funding round (RFID-based products for safety in surgical/medical applications)
  • Femasys, Inc., has raised $1.03 million of a planned $5 million round of financing according to a regulatory filing (fallopian tube and uterine diagnostics)

July

  • Replication Medical, Inc., has raised $1.1 million in funding according to a regulatory filing (implantable hydrogel devices used in spine surgery)
  • Sensus Healthcare, LLC, has raised $1.5 million of a planned $7 million round of funding according to a regulatory filing (medical technology development)
  • Figure 8 Surgical, Inc., has raised $1.36 million of a planned $1.5 million round of funding according to a regulatory filing
  • Seguro Surgical, Inc., has raised $125K of a planned $1.25 milllion funding round (surgical instrumentation)
  • Tissue Genesis, Inc., has raised $1.33 million of a planned $15.3 million round of funding according to a regulatory filing (tissue engineering and cell therapy)
  • BIO2 Technologies has raised $1.1 million of a planned $2 million round of funding (tissue engineering scaffolds)
  • Smart Pill Corp. has raised $7.95 million of a planned $9.5 million round of funding according to a regulatory filing (pill camera GI diagnostic)
  • Cambus Medical has raised $1.89 million (€1.5 million) in a new round of funding (advanced catheter component solutions)
  • Cappella Inc. has raised $3.69 million of a planned $9.9 million round of funding according to a regulatory filing (treatment of bifurcation in coronary artery disease)
  • Uptake Medical, Inc., has raised $17.5 million in a Series B funding round (device for treatment of emphysema)
  • Neoprobe Corp. has raised $14 million in funding (gamma detection technology in sentinal node biopsy)
  • DFine, Inc., has raised $36.2 million in financing (minimally invasive treatments of vertebral compression fractures)
  • EyeTechCare has raised $9.5 million (€7.5 million) in a new round of funding (high intensity focused ultrasound (HIFU) for treatment of glaucoma)
  • Theranos, Inc., has raised $45 million of a planned $100 million round of funding (medical devices that monitor drug reactions)
  • TriVascular, Inc., has raised $60 million in a new round of funding (technology for repair of abdominal aortic aneurysms)
  • Ventus Medical Inc. has raised $40 million in a Series D round of funding (medical device technology for treatment of sleep disordered breathing)
  • InVasc Therapeutics, Inc., has raised $3.2 million of a planned $12 million round of funding according to a regulatory filing (drugs for kidney disease and atherosclerosis)
  • Innocoll Holdings, Inc., has raised $5 million in funding according to a regulatory filing (collagen-based drugs and devices)
  • Vertiflex, Inc., has raised $2 million in funding according to a regulatory filing (non-fusion spine surgery technologies)
  • Providien, Inc., has raised $10.5 million in seed funding (undisclosed medical device technology, principal investor Endeavor Capital)
  • BBARRX Medical, Inc., has raised $15 million in a Series D round of funding (endoscopic treatments for GI diseases)
  • Invuity, Inc., has raised $13.2 million of a planned $16 million round of funding (lighting and visualization in minimally invasive surgical instrumentation)
  • EndoStim, Inc., has raised $6 million in a Series B financing (device treatment sphincter-related disorders such as GERD and urge uinary incontinence)
  • Gentis, Inc., has raised $548K of a planned $2.25 million round of funding (orthobiologics products)
  • AxioMed Spine Corp. has raised $14.5 million in a round of funding (spinal disc implants)
  • Nfocus Neuromedical, Inc., has raised $3.31 million of a planned $7.15 million funding round (device treatment of brain aneurysms)
  • Maya Medical, Inc., has raised $700K in an apparent seed financing (company founded by Motasim Sirhan, founder of Avantec Vascular)
  • inCyte Innovations, LLC, has raised $3 million in funding according to a regulatory filing
  • SuperDimension Ltd. has raised $9.8 million in a funding round (technology to detect and map lung cancer)
  • USHIFU, Inc., has raised $1.02 of a planned $10 million funding round according to a regulatory filing (therapeutic use of high intensity focused ultrasound)
  • Devicor Medical Products Group, LLC, has raised $151.5 million from seven investors to fund development of breast-care business (now named Mammotome) from J&J’s Ethicon Endo-Surgery.
  • IDEV Technologies, Inc., has raised $27.7 million of a planned $44.8 million round of financing according to a regulatory filing (biliary stent technologies)
  • Sound Surgical Technologies, LLC, has raised $2.1 million of a planned $5 million funding round (ultrasound based liposuction for cosmetic surgery)
  • Avedro, Inc., has raised $4.58 million in funding according to a regulatory filing (non-invasive procedure for treatment of keratoconus in vision correction)
  • InfraReDx, Inc., has raised $1.53 million in a round of funding according to a regulatory filing (infrared imaging of blood vessels for catheterization)
  • Aethlon Medical, Inc., has raised $890K in a round of funding according to a regulatory filing (blood purifier to treat infectious diseases)

June

  • NanoPowers SA has raised CHF 5 million ($4.5 million) in a Series A financing (developing artificial muscle technology including for artificial urinary sphincter)
  • Altura Medical, Inc., has raised an additional $12 million, bringing its current round of funding to $20 million (devices for the treatment of abdominal aortic aneurysm)
  • Minimus Spine, Inc., has raised $925K of a planned $1.7 million round of funding according to a regulatory filing (ozone injection technology for treatment of spinal disc herniation)
  • Follica, Inc., has raised $7.5 million in a Series C round of funding (device technology for the treatment of hair follicle disorders)
  • ZELTIQ has raised $20 million in a Series D funding (device to remove fat via cold lypolysis)
  • Uptake Medical, Inc., has raised $600K in a round of funding according to a regulatory filing (devices for treatment of emphysema and COPD)
  • Anulex Technologies, Inc., has raised $18.3 million of a planned $20 million Series E round of funding according to a regulatory filing (technologies to preserve soft tissue of spine for patients undergoing discectomy)
  • EarlySense Ltd has raised $13 million in funding (non-contact patient monitoring system)
  • AqueSys, Inc., has closed on $35 million funding in a Series C round (device for treatment of glaucoma)
  • AtheroNova, Inc., has raised $10.7 million in funding according to a regulatory filing (biopharmaceuticals targeted at atherosclerosis)
  • NeoVista, Inc., has raised $3.2 million of a planned $12 million round of funding according to a regulatory filing (epiretinal device for treatment of wet AMD)
  • PorOsteon Orthopedics, Inc., has raised $2.2 million of a planned $2.5 million round of funding (undisclosed orthopedic device technology)
  • Exogenesis Inc. has raised $3.7 million of a planned $4.1 million round of funding (surface modification technologies for medical devices)
  • Sebacia, Inc., has raised $2.5 million according to a regulatory filing (medical technology portfolio company of The Innovation Factory)
  • OptiNose AS has received commitment of $48.5 million in funding from Avista Capital Partners (nasal drug delivery technology)
  • MoMelan Technologies, Inc., has raised $1.08 million in funding (device to improve skin grafting)
  • Access Scientific, Inc., has raised $2.6 million of a planned $2.9 million funding round (vascular insertion device)
  • Lonestar Heart, Inc., has raised $10.2 million of a planned $15 million round of funding according to a regulatory filing (acquired CardioPolymers, developing biocompatible polymer implant therapies for treatment of CHF, valve and fibrillation)
  • CytoPherx, Inc., has raised $11.7 million of a planned $12 million funding round according to a regulatory filing (cytopheresis device based treatment of inflammatory diseases)
  • SafeStitch Medical, Inc., has raised $5 million in funding through a new issuance of stock (endoscopic and minimally invasive surgical devices)
  • Aradigm Corporation has raised $5 million in a private placement (pulmonary drug delivery)
  • Neosync, Inc., has raised $3.4 million of a planned $10 million funding round according to a regulatory filing (neuro-EEG treatment of depression)
  • EpiEP, Inc., has raised $1 million in funding (technology for minimally invasive pericardial access in treatment of cardiac arrhythmias)
  • Baxano, Inc., has raised $30 million in a Series C funding (technology for decompression during spine surgery)
  • Monteris Medical, Inc., has raised $3.4 million in a round of funding (laser-based thermal therapy for brain surgery)
  • Voyage Medical has raised $20.6 million of a planned $21.1 million according to a regulatory filing (RF catheter ablation of atrial fibrillation employing visualization system)
  • Incline Therapeutics has raised $22 million of a planned $43 million round of funding according to a regulatory filing (post-surigical, patient controlled analgesia through drug/device system)
  • HemoSonics, Inc., has raised $1 million in funding according to a regulatory filing (sonorheometry diagnostic device for bleeding disorders)
  • Tarsus Medical, Inc., has raised $510,000 in a round of funding (podiatry applications)
  • Del Palma Orthpedics LLC has raised $1.4 million of a planned $2 million round of funding according to a regulatory filing (orthopedic instrumentation development)
  • Cayenne Medical, Inc., has raised $3.6 million of a planned $9.54 million funding round (technologies in cruciate ligament reconstruction)
  • PharmacoPhotonics has raised $1.5 million in funding (device to measure kidney glomerular filtration rate)
  • SRS Medical Systems, Inc., has raised $3.77 million in funding according to a regulatory filing (devices for measurement of urodynamics and treatment of urinary incontinence)
  • CAS Medical Systems, Inc., has raised $1.925 million in funding according to a regulatory filing (patient monitoring systems)

May

  • CoRepair, Inc., has raised $4.49 million of a planned $5.73 million round of financing (radiofrequency ablation treatment of congestive heart disease)
  • Respirics, Inc., has raised $3.7 million of a planned $4.6 million funding round according to a regulatory filing (inhalation-based drug delivery technology)
  • Entrigue Surgical, Inc., has raised $10.88 million of a planned $11.38 million funding round according to a regulatory filing (surgical instrumentation for ENT)
  • TearScience has raised $44.5 million in a Series C funding round, according to the company (diagnostic and treatment devices for evaporative dry eye)
  • CardioMEMS, Inc., has raised $37.9 million in financing, according to the company (implantable wireless sensor for cardiac monitoring)
  • BIO2 Medical, Inc., has raised $7.5 million in a Series B round (nitinol vena caval filter)
  • Envoy Medical, Inc., has raised $330K of a planned $16.5 million round of financing (implantable hearing device)
  • Gynesonics, Inc., has raised $15.12 million in a planned $20.64 million round of financing (device for minimally invasive treatment of uterine fibroids)
  • Audax Medical, Inc., has raised $551K in a round of financing according to a regulatory filing (surgical instrumentation and osteogenic biomaterials for spine surgery)
  • NuOrtho Surgical, Inc., has raised $250K toward a planned $1.5 million round of financing according to a regulatory filing (radiofrequency surgical applications in orthopedics)
  • Pluristem Therapeutics, Inc., has raised $250K in a funding according to a regulatory filing (cell therapies for several severe degenerative, ischemic and autoimmune disorders)
  • Sequent Medical, Inc., has raised $15.6 million in a round of funding (endovascular treatment of aneurysm)
  • Small Bone Innovations, Inc. (treatments and technologies for small bones and joints), has received a $12 million investment from Olympus Corporation
  • Palmaz Scientific Inc., has raised $3 million in a recent funding (nanotech surfaces for implantable medical devices)
  • XLumena, Inc., has raised $3 million according to a regulatory filing (devices to enable endoscopic ultrasound-guided translumenal therapy)
  • Breathe Technologies, Inc., has raised $23 million in Series C funding (patient ventilation technology)
  • Tenaxis Medical, Inc., has raised $780K toward a planned $4.3 million round of financing (sealants and anti-adhesion products for vascular and general surgery)
  • iRhythm Technologies, Inc., has raised $10 million in funding according to a regulatory filing (cardiac rhythm monitoring)
  • Leonardo Biosystems, Inc., has raised $1.25 million of a planned $2.5 million round of funding according to a regulatory filing (nanotech-based drug delivery technologies)
  • ReVision Optics, Inc., has raised $35 million in funding according to a regulatory filing (implanted lens replacement for patients with presbyopia)
  • Arsenal Medical, Inc., has raised $10 million in funding according to a regulatory filing (biomaterials-based therapeutics based on bioactive composites)
  • O2 MedTech, Inc., has raised $2 million in funding according to a regulatory filing (early stage medical device company)
  • Oncoscope, Inc., has raised $1.2 million of a planned $1.5 million round of funding according to a regulatory filing (optical biopsy)
  • Inova Labs, Inc., has raised $10 million in a private placement funding (portable oxygen concentrator)
  • Celula, Inc., has raised $15 million in a recent funding (noninvasive prenatal diagnostics)
  • CardioDx, Inc., has raised $34.56 million in Series D funding toward a planned $44.54 million round (cardiovascular genomic diagnostics, including to identify obstructive coronary artery disease)
  • BioControl Medical Ltd. (implantable nerve stimulation device) will receive a $70 million investment from Medtronic, Inc.
  • Biomedical Structures, LLC_ has raised $3.75 million in funding (biomaterials and textikes for medical devices)
  • Delphinus Medical Technologies, Inc., has raised $8 million in funding (ultrasonic breast cancer detection device)
  • RF Surgical Systems, Inc., has raised $2.5 million of a planned $5 million round of financing (technologies to detect and prevent retained surgical sponges)
  • Altura Medical, Inc., has raised $8 million in funding according to a regulatory filing (low profile stent graft for abdominal aortic aneurysm)
  • HepaLife Technologies, Inc., has raised $12.025 million in funding according to two regulatory filings (bioartificial liver)
  • SpineFrontier, Inc., has raised $500K according to a regulatory filing (surgeon-innovated technologies in spine surgery)
  • Pathfinder Therapeutics, Inc., has raised $3 million of a planned $4 million funding round according to a regulatory filing (intraoperative surgical navigation)
  • Keraplast Technologies, Inc., has raised $2.5 million of a planned $5 million funding round (wound healing and bone regeneration based on keratin)
  • Cohera Medical, Inc., has raised $12.2 million of a planned $19.94 million round of funding (bioabsorbable surgical adhesive)
  • Dune Medical Devices Ltd has raised $7.7 million of a potential $12.7 million round of funding (device for rapid detection of breast cancer during surgery)

April

  • CleveX, Inc., has received the second tranche of its $1.7 million Series B funding round (device to facilitate skin biopsies)
  • Diamyd Medical AB has raised $4.89 million (35 million SEK) in funding (pharmaceuticals for the treatment of autoimmune diabetes and its complications)
  • Exos Corp. has raised $925K of a planned $1 million round of financing according to a regulatory filing (polymer based cast alternative)
  • Small Bone Innovations, Inc., has raised $12 million in financing according to a regulatory filing (technologies focused on small bone & joint)
  • Viacor, Inc., has raised $6.58 million in financing through a debt and securities sale (catheter-based treatment of valve disease)
  • WaveRx, Inc., has raised $500K in an equity offering according to a regulatory filing (medical device technology to treat disorders of the nail and skin)
  • Hemosphere, Inc., has raised $9.3 million in a Series A funding (technology to aid in vascular access as in renal dialysis)
  • Svelte Medical has raised $3 million to complete its Series A financing, adding to the $6 million received in November 2009 (developing a non-thrombogenic, non-inflammatory drug-eluting stent)
  • Stratatech, Inc., has raised $3 million in funding according to a regulatory filing (genetically engineered skin substitute)
  • LaZure Scientific has raised $2 million of a planned $3 million funding round (treatment of cancer via low intensity electric fields)
  • Articulinx, Inc., has raised $10 million in a second round of funding (device-based treatment of osteoarthritis)
  • OrthoHelix Surgical Designs Inc., has added $4.6 million to its Series C funding round (implants and instruments for foot, ankle, hand and wrist surgeries)
  • VasoNova, Inc., has raised $2.24 million of a planned $7.8 million round of funding (ultasound guidance for vascular access devices)
  • Exsulin Corp. has raised $120K toward a planned $1.5 million funding round (pancreatic islet cell regeneration for Type 1 diabetics)
  • Denali Medical has raised $4 million according to a regulatory filing (medical device incubator)
  • Hyperbranch Medical Technology, Inc., has raised $2.1 million in funding according to a regulatory filing (products, including sealants, for use in ocular surgery)
  • Veran Medical Technologies, Inc., has raised $950K toward a planned $1.945 million funding round (image guidance system in interventional radiology)
  • Asalus Medical Instruments Ltd has raised $687K (£450K) in its first funding round (instruments to assist in laparoscopic surgery)
  • Bovie Medical has raised $3 million via private placement (electrosurgical instruments)
  • CardioFocus, Inc., has raised $5 million in funding according to a regulatory filing (ablation treatment of cardiac disorders, atrial fibrillation, AFib heart arrhythmia)
  • Soft Tissue Regeneration, Inc., has raised $500K from Connecticut Innovations (tissue regeneration of anterior cruciate ligament)
  • Pluromed, Inc., has raised #1.1 million of a planned $3.9 million funding round (hydrogel products used during lithotripsy and other procedures)
  • Tissue Genesis, Inc., has raised $1.12 million of a planned $9 million funding round (advanced tissue engineering and cell therapy based on adipose tissue)
  • Cytomedix, Inc., has raised $3.65 million in a funding round according to a regulatory filing (tissue regeneration in wound care, angiogenesis, and inflammation)
  • Facet Solutions, Inc., has raised $2.12 million in a funding round according to a regulatory filing (devices for facet arthroplasty)
  • ALung Technologies, Inc., has raised $2.8 million in a recent funding (respiratory assistance technology to provide catheter-based oxygenation via femoral or jugular vein)
  • Nevro Corp. has raised $20 million in funding according to a regulatory filing (neuromodulation therapies for indications such as chronic pain)
  • Spiration, Inc., has raised $6.5 million in a funding round according to a regulatory filing (devices for the treatment of emphysema)
  • InTouch Technologies, Inc., has raised $10 million of a planned $11 million round of funding according to a regulatory filing (remote presence technologies)
  • NeoVista, Inc., has raised $3 million in a round of funding according to a regulatory filing (technologies for the treatment of wet age-related macular degeneration)
  • Biomimedica has raised $600K of a planned $2.4 million round of financing (synthetic cartilage for joint repair)
  • Harbinger Medical, Inc., has raised $550K in a round of funding according to a regulatory filing (electrocardiograph)

March

  • Isis Biopolymer has raised $3 million in funding according to a regulatory filing (transdermal drug delivery)
  • Access Closure has raised $10 million in funding (closure and sealing of femoral puncture site following interventional procedure)
  • Reverse Medical Corp. has received $12.8 million in a funding round according to a regulatory filing (embolic protection systems)
  • TransMedics, Inc., has raised $36 million a funding round (support system for donor organs)
  • Soluble Systems, LLC, has raised $1.3 million in funding according to a SEC filing (advanced sterile wound dressings)
  • Carticept Medical, Inc., has raised $20 million in a Series B round of financing (synthetic cartilage implant)
  • OsteoSpring Medical, Inc., has received $950K of a planned $2.5 million financing round according to a regulatory filing (osteobiologics under development by former President/CEO of NeuColl)
  • Solta Medical, Inc., has raised $4.75 million of a planned $15.5 million round of financing according to a regulatory filing (radiofrequency-based technology for cosmetic skin procedures)
  • Veryan Medical Ltd has raised $5.5 million (€4 million) in a round of financing (stents based on swirling blood flow)
  • FluidNet Corp. has raised $9.08 of a planned $9.92 million funding round (infusion delivery device)
  • Amedica Corp. has raised $11.5 million of a planned $30 million funding round according to a regulatory filing (orthopedic biomaterials)
  • Cheetah Medical, Inc., has raised $20 million in Series B funding (non-invasive hemodynamic monitoring)
  • Rhythmia Medical Inc. raised nearly $2.7 million in a Series B funding (heart mapping device to guide arrhythmia ablation procedures)
  • EMKinetics, Inc., has raised $2.8 million of a planned $3.35 million round of funding (neuromodulation, initially for urinary incontinence)
  • Spinal Restoration, Inc., has raised $20 million in a round of funding according to a regulatory filing (non-surgical system for treatment of chronic back pain)
  • NonLinear Technologies Ltd has raised $8.8 million in funding (motion preservation and percutaneous options in spine surgery)
  • Applied StemCell has raised $1.88 million of a $2.45 million funding according to a regulatory filing (Stem cell culture, cell lines, assays, cell replacement therapies)
  • Arsenal Medical, Inc., has raised $1 million in financing (biomaterials-based therapeutics based on bioactive composites)
  • Rotation Medical, Inc., has raised $3.88 million of a planned $4.41 million round of investment (undisclosed medical device technology)
  • Z&Z Medical Holdings, Inc., has raised $5 million in funding according to a regulatory filing (dissolution of arterial plaques via elevation of bile salts)
  • Sequent Medical, Inc., has raised $1 million in funding according to a regulatory filing (devices for endovascular treatment of neuovascular disease)
  • SmartCells, Inc., has raised $1.75 million of a planned $4 million funding round according to a regulatory filing (insulin bound to a “polymer-therapeutic” to produce glucose-concentration-specific insulin release)
  • Novocell, Inc., has raised $304K of a planned $2 million round of funding according to a regulatory filing (encapsulated cellular transplants for the treatment of diabetes and other diseases)
  • Hemosphere, Inc., has raised $9.35 million in funding according to a regulatory filing (vascular access device)
  • OxyBand Technologies, Inc., has raised $700K of a planned $11 million round of funding (oxygen-based wound dressing)
  • Anulex Technologies, Inc., has raised $3.8 million in funding according to a regulatory filing (spine surgery devices)
  • White Pine Medical, Inc., has raised $1 million of a planned $57 million (yes, $57M) total offering (late stage medical device acquisitions)
  • JenaValve Technology GmbH has raised $25.65 million ( €19 million) in a Series B round of financing (minimally invasive aortic valve replacement)
  • Reverse Medical Corp. has raised $14 million in a Series B funding round (microcatheters for treatment of neurovascular disorders)
  • Imthera Medical, Inc., has raised $520K of a planned $3.5 million funding round (neurostimulation device for treatment of obstructive sleep apnea)

February

  • Valtech Cardio Ltd. has received $17.8 million in Series B funding (minimally invasive surgical and transcatheter mitral valve repair and replacement technologies)
  • Tepha, Inc., has raised $3 million in financing according toa regulatory filing (polymers and elastomers used in medical devices)
  • OrthAlign has received $5.2 million in a Series A2 financing (computer-assisted knee surgery system)
  • Resoimplant GmbH has received $3.5 million in its third round of financing (bioabsorbable orthopedic implants)
  • CytoSolv Inc. has raised $500K in seed financing (development of choroid plexus protein technology for wound management)
  • CardioInsight Technologies Inc. has raised $6 million in Series B financing (non-invasive cardiac mapping)
  • MicroTransponder, Inc. has raised $7 million in a Series B financing (wireless neurostimulation for treatment of chronic pain, other neuro)
  • ALung, Inc., raises $3.3 million in an undisclosed round of financing (intravascular lung oxygenation device to replace/supplement hospital ventilators)
  • Calibra Medical Inc. has raised $9.2 million of a planned $32.3 million round of financing (portable insulin delivery device)
  • InSight Medical Technologies, Inc., has raised $1.06 million of a planned $2.08 million round of funding (device for epidural anesthesia)
  • SpineAlign Medical, Inc., has raised $1.64 million of a planned $6.9 million funding round according to a regulatory filing (vertebral body spinal replacement)
  • Intuity Medical, Inc., has raised $40.68 million of a planned $64.22 million funding round according to a regulatory filing (simplified blood glucose monitor)
  • Parcus Medical, Inc. has raised $1.3 million in a planned $2 million round of funding (surgical instrumentation)
  • Flexible Medical Systems, LLC, has raised $1.34 million in a new round of funding (remote transdermal biomonitoring)
  • Salutaris Medical Devices, LLC, has raised $1.3 million in funding according to a regulatory filing.
  • Vyteris, Inc., has raised $1.06 million of a planned $7 million funding round according to a regulatory filing (transdermal drug delivery)
  • Adhezion Biomedical has raised $2.5 million of a planned $3.4 million round of funding, according to a regulatory filing (cyanoacrylate-based adhesives and sealants)
  • Imricor Medical has raised $3.07 million in funding according to a regulatory filing (ablation catheter for treatment of atrial fibrillation)
  • Intrinsic Therapeutics, Inc., has raised $18 million in funding according to a regulatory filing (treatment of soft tissue injuries of the spine)
  • Pulmonx has raised $32 million in a new round of funding (minimally invasive devices for treatment of pulmonary disorders)

January

  • Proteus Biomedical, Inc., has raised $25.45 million in a new funding round according to a regulatory filing (management of congestive heart failure)
  • HistoSonics, Inc., has raised an additional $6 million in funding, bringing its Series A round to $11 million (ultrasound based tissue ablation for BPH, others)
  • Intuity Medical, Inc., has raised $64 million in Series D financing (integrated blood glucose monitor)
  • CeQur SA has raised $30 million in a Series A funding (subcutaneous insulin patch for Type 2 diabetes)
  • CircuLite, Inc., has closed a Series C funding of $32.5 million (micro-pump for circulatory support in congestive heart failure)
  • Michelson Diagnostics Ltd has received $1.1 million in new funding (developing optical coherence tomography)
  • ValenTx Inc. has raised $22 million in a Series B funding ( less-invasive, implantable medical device to address morbid obesity)
  • Neuralstem, Inc., has raised $1.5 million in financing (stem cell therapy in CNS disorders including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease)
  • MicroCHIPS, Inc., has raised $16.5 million in Series C financing (wireless implants for diagnostics and drug delivery)
  • GI Dynamics, Inc., has raised $15 million in Series C financing from sole investor Medtronic (EndoBarrier Gastrointestinal Liner for treatment of obesity)
  • MiMedx, Inc., has raised $5 million in a private placement funding (biomaterials for tissue augmentation and repair)
  • Heart Force Medical Inc., has raised $4.8 million in funding (developing digital Ballistocardiograph for non-invasive cardiac assessment)
  • Salient Surgical, Inc., has raised $15 million in funding (RF-based system for wound sealing/closure)
  • Microfabrica, Inc., has raised $22.5 million in Series B funding (minimally invasive medical devices)
  • Endogun Medical Systems, Ltd. (changing name to Israel Biomedical Innovations), has raised $12.5 in funding (minimally invasive suturing)
  • TVA Medical, Inc., has raised $2.6 million in a Series A financing round (minimally invasive treatments for end stage renal disease)
  • Crospon has raised $2.9 million (€2 million) in funding (diagnostic tool for use in gastroesophageal reflux disease)
  • Tandem Diabetes has raised $31 million in funding, bringing its current round to $52.3 million (insulin pumps)
  • Apama Medical, Inc., has raised $1.1 million in seed funding (treatment of atrial fibrillation)
  • Solta Medical, Inc., has raised $17.2 in funding (radiofrequency and laser based aesthetic treatments of skin)
  • Advanced Cardiac Therapeutics, Inc., has raised $5 million in Series B funding (irrigated cardiac ablation systems)
  • Dfine, Inc., has raised $2.83 million in funding according to a regulatory filing (treatment of vertebral compression fractures)
  • Neuralieve, Inc., has raised $3.89 million of a planned $7.5 million round of funding according to a regulatory filing (non-invasive device for treatment of neurological problems, including migraine)
  • Promethean Surgical Devices, Inc., has raised $3.68 million in funding according to a regulatory filing (polymer technology for surgical adhesives and implants)
  • Cerevast Therapeutics, Inc., has raised $2 million in funding according to a regulatory filing (sonolysis for treatment of vascular thrombus disorders)
  • CuMed LLC has raised $4 million in funding according to a regulatory filing (undisclosed nanotech medical technology)
  • Windmill Cardiovascular Systems, Inc., has raised $1 million in funding according to a regulatory filing (left ventricular assist device)
  • CHF Solutions, Inc., has raised $1.82 million in funding according to a regulatory filing (treatment of congestive heart failure)
  • InfraReDx, Inc., has raised $10 million in funding according to a regulatory filing (identification and stabilization of vulnerable plaque)
  • EBS Technology GmbH has raised $4.34 million (€3 million) in a Series B financing (devices for treatment of neurological deficit from stroke and trauma)
  • BioPoly LLC has raised $2 million in its first round of financing (polymer for orthopedic implants)
  • Enteromedics, Inc., has raised $4.8 million in funding through sale of its stock to institutional investors (device therapies for vagal-mediated disorders)
  • Cardiorobotics, Inc., has raised $5 million funding according to a regulatory filing (surgical devices used to enhance endoscopic surgery)
  • ConforMIS, Inc. has raised $2.16 million in financing according to a regulatory filing (patient-specific implants and instrumentation)
  • Pulmonx, Inc., has raised $11.5 million in bridge round financing (minimally invasive devices for treatment of pulmonary disorders)
  • Arsenal Medical, Inc., has raised $2 million in funding according to a regulatory filing (biomaterials-based therapeutics based on bioactive composites)
  • InSite Medical, Inc., has raised $1 million of an expected $2 million in funding (epidural anaesthesia delivery)
  • Cohera Medical, Inc., has raised $10 million in a planned $25 million Series C financing round according to Dow Jones VentureWire (surgical glue used in aesthetic procedures)
  • Solta Medical, Inc., has raised $17.2 million in funding according to a regulatory filing (radiofrequency and laser aesthetic treatment of skin)
  • Luna Innovations, Inc., has raised $7.1 million in funding according to a regulatory filing (optical components in medical device, equipment and other applications)
  • Amedrix GmbH has raised $987K in seed financing (collagen-based implants for repair of soft tissue defects)
  • Axogen, Inc., has raised $3.36 million in financing, toward a planned $4.7 million round, according to a regulatory filing (nerve grafts to repair and regenerate damaged peripheral nerves)
  • Minerva Surgical, Inc., has raised $1 million in financing according to a regulatory filing (endometrial ablation of abnormal uterine bleeding)
  • NeoGraft, Inc., has raised $6.3 million in financing according to a regulatory filing (new device for structural support of veins for arterial vein grafts)
  • OrthoAlign, Inc., has raised $5.2 million in a Series A2 tranche (computer-assisted surgical device in orthopedic surgery)
  • Cellular Dynamics International, Inc., has raised $31.3 million in funding according to a regulatory filing (pluripotent stem cells, such as cardiomyocytes, used for drug discovery)
  • NeoMend, Inc. has received $30 million in funding (products used in sealing of surgical wounds)

2017   2016   2015   2014   2013   2012   2011   2010   2009